Literature DB >> 10843294

Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesions.

G Martignoni1, M Pea, G Rigaud, E Manfrin, C Colato, G Zamboni, A Scarpa, R Tardanico, M Roncalli, F Bonetti.   

Abstract

Angiomyolipoma (AML) is a benign neoplasm that occurs either sporadically or in patients with tuberous sclerosis complex (TSC) and shows frequent allelic losses at chromosome arm 16p. It has been suggested recently that the melanogenesis marker-positive perivascular epithelioid cell (PEC) has been found consistently in AML. The authors report a 50-year-old woman without evidence of TSC affected by classic renal AML containing an area composed of atypical epithelioid cells with the same morphoimmunophenotypic characters of PEC. After 7 years from surgical removal of the lesion, the patient developed a local recurrence and successive lung and abdominal metastases that showed morphologic and immunohistochemical features overlapping those of the epithelioid area of the previously removed AML. Genetic analysis showed that the classic AML and its epithelioid area as well as the pulmonary and abdominal metastases shared the same allelic loss on chromosome arm 16p. Based on these findings, the authors view this case as evidence of a malignant transformation of a classic AML with morphologic, immunophenotypic, and genetic demonstration of its clonal origin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843294     DOI: 10.1097/00000478-200006000-00017

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

1.  A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation.

Authors:  P Argani; A Hawkins; C A Griffin; J D Goldstein; M Haas; J B Beckwith; C B Mankinen; E J Perlman
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

2.  "Sugar" tumor of the pancreas: a rare entity that is diagnosable on preoperative fine-needle biopsies.

Authors:  Olivier Ramuz; Bernard Lelong; Marc Giovannini; Jean-Robert Delpero; Philippe Rochaix; Luc Xerri; Jacques Hassoun; Jean-François Flejou; Geneviève Monges
Journal:  Virchows Arch       Date:  2005-04-09       Impact factor: 4.064

3.  Colonic angiomyolipoma with a monotypic expression and a predominant epithelioid component.

Authors:  M Abdulkader; J Abercrombie; T A McCulloch; P V Kaye
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

4.  Aggressive Angiomyolipomas: the Clandestine Epithelioid Variant.

Authors:  Anton Maré; Shehan Wickramasinghe; Victor Ilie; Maurice Mulcahy
Journal:  Curr Urol       Date:  2016-02-10

5.  Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma.

Authors:  Cheng-Keng Chuang; Hsin Chia Angela Lin; Han-Yu Tasi; Kun-Han Lee; Yuting Kao; Fukai Leo Chuang; Ying-Hsu Chang; Po-Hung Lin; Chung-Yi Liu; See-Tong Pang
Journal:  Int Urol Nephrol       Date:  2017-05-25       Impact factor: 2.370

Review 6.  Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond.

Authors:  Elizabeth Petri Henske
Journal:  Pediatr Nephrol       Date:  2005-04-26       Impact factor: 3.714

7.  Epithelioid angiomyolipoma: imaging appearances.

Authors:  N Bharwani; T J Christmas; C Jameson; N Moat; S A Sohaib
Journal:  Br J Radiol       Date:  2009-12       Impact factor: 3.039

8.  Multifocal angiomyolipoma affecting the liver and lung without tuberous sclerosis.

Authors:  M Saito; T Tsukamoto; T Takahashi; K Sai; H Fujii; K Nagashima
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

9.  Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms.

Authors:  Heidi Kenerson; Andrew L Folpe; Thomas K Takayama; Raymond S Yeung
Journal:  Hum Pathol       Date:  2007-05-22       Impact factor: 3.466

10.  Functional tyrosine kinase inhibitor profiling: a generally applicable method points to a novel role of platelet-derived growth factor receptor-beta in tuberous sclerosis.

Authors:  Jack L Arbiser; Baskaran Govindarajan; Xianhe Bai; Hiroaki Onda; Andrius Kazlauskas; So Dug Lim; Mahul B Amin; Lena Claesson-Welsh
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.